Browsing Category

Sponsored Content

47 posts

OLON GROUP ANNOUNCES THE ACQUISITION OF GTP BIOWAYS GROUP 

GTP Bioways Group is a French company operating as a biotech CDMO (contract development and manufacturing organization), specializing in R&D services, process development, and production of monoclonal antibodies (mAbs), enzymes,…

Global Scenario: Opportunities and Challenges in Peptides 

Sponsored by Olon  In just the last five years, the US Food and Drug Administration (FDA) has approved no fewer than 14 peptides with therapeutic activities. Today, there are around…

Present And Future of Oncology: What Is Needed from API Suppliers? 

Oncology is one of the most important growth markets for the pharmaceuticals industry, partly because of the increasing prevalence of cancer in a world population that is growing and living…

CUSTOM SERVICES: INDENA’S APPROACH AND EXPERTISE  

Custom Development & Manufacturing Organization services have been one of the key areas of Indena’s expertise since the 1990s.  Leveraging its analytical and manufacturing capabilities, Indena positions its services in…

Formulation Considerations for Pediatric Populations: Finding the Right Dosage Form for Better Adherence

To address the challenges of pediatric formulations, specialized technology platforms are often needed to provide ease of application and improve patient outcomes By Adare Pharma Solutions Pediatric populations represent the…

Q&A: The growing importance of supply chain security within API manufacturing

Executive Summary Q&A What are the challenges faced by the pharma industry?Pharma professionals are grappling with the fact that drug development is becoming more complicated. There are more modalities, more…

Unveiling the Pharma Revolution: Polpharma’s Leap in API Development and Manufacturing Services

In the dynamic landscape of pharmaceuticals, the surge in demand for drug substance development and cGMP manufacturing services has become more palpable than ever. Over the past few years, a…

Addressing Challenges with Clinical In-Use Testing of Biotherapeutics

Ensuring patient safety in early and late-phase product development By Léa Sorret, Principal Scientist & Group Lead in Formulation Development Drug Product Services, Lonza IntroductionAll clinical in-use testing of biotherapeutics…

CDMO Insights: Key Considerations in Sterile and Non-Sterile Outsourcing

Authors: Shawn Cain:                      SVP Development and Manufacturing, Injectables Louise Carpenter:             Head of Pharmaceutical Development Picture the scenario. You’ve spent several years, and hundreds of millions of dollars, developing your…

Overcome Challenges and Secure Successful Technology Transfers of Complex Biological Products in Sterile Manufacturing

By Angela Armanni, Senior Director, Global Head MSAT, Drug Product Services, Lonza The biopharmaceutical industry has seen many challenges in the last few years, spawned not just by a global…